Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer

Conditions:   Clear Cell Renal Cell Carcinoma;   Locally Advanced Unresectable Renal Cell Carcinoma;   Stage III Renal Cell Cancer AJCC v8 Intervention:   Drug: Cabozantinib Sponsors:   Emory University;   Exelixis Not yet recruiting

Source: ClinicalTrials.gov - July 17, 2019 Category: Research Source Type: clinical trials